SP1 and non-small cell lung carcinoma: In this study, we explored the mechanism of piperlongumine’s effect in osimertinib-resistant NSCLC cells, and our report indicated that the Sp1/c-Met axis plays a critical role in promoting osimertinib resistance in NSCLC cells.